Brian Low
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Brian Low has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Alisa Hui
Department of Chemistry, University of British Columbia, Vancouver, Canada
17 shared publications - Cheri A. Pasch
Division of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA
17 shared publications - Chunmiao Cai
Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin–Madison, Madison, Wisconsin
17 shared publications - Dustin A. Deming
Division of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, USA
17 shared publications - Fei Sun
Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin–Madison, Madison, Wisconsin
17 shared publications - Henry Secaira-Morocho
Center for Fundamental and Applied Microbiomics and School of Life Sciences, Arizona State University, Tempe, USA
17 shared publications
Latest Publications
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
Impact of microbially LCAs on CRC cells growth
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
Impact of microbially LCAs on CRC cells growth
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 10 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA inhibits tumor progression in PDX2 mice
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 10 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA inhibits tumor progression in PDX2 mice
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 13 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA reshape the gut microbiome pool in APCMin/+ mice
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 13 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA reshape the gut microbiome pool in APCMin/+ mice
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA decreases tumor load in CT26-xenograft Balb/c mice
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA decreases tumor load in CT26-xenograft Balb/c mice
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 9 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA decreases tumor load in xenografted mice
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 9 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA decreases tumor load in xenografted mice
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA Inhibits CT26 Cell Growth by Activating FXR Signaling and inducing apoptosis
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA Inhibits CT26 Cell Growth by Activating FXR Signaling and inducing apoptosis
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA stimulates Intestinal Stem Cell (ISC) proliferation in WT intestinal organoids
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA stimulates Intestinal Stem Cell (ISC) proliferation in WT intestinal organoids
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 11 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
The effect of 3-oxo-LCA is FXR-dependent
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 11 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
The effect of 3-oxo-LCA is FXR-dependent
- Open Access
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 12 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA reshape the BAs pool in APCMin/+ mice
- 15 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 12 from The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer Progression
3-oxo-LCA reshape the BAs pool in APCMin/+ mice